home

AUPH.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Comparison for AUPH, Aurinia Pharmaceuticals Inc

The comparison is made between AUPH and the comparison stocks RMT and CLMT

Sales

For the financial year , Aurinia Pharmaceuticals Inc sales were $7.16 million and 99.3% under the average of $1019.66 million After cost of goods, and selling and general costs, gross income were $7.16 million and 94.57% under the average of $131.86 million The profit margin were a lot the highest of the comparisons and 77.24% higher than the average of a lot

Assets

For the year ending in , Aurinia Pharmaceuticals Inc net current assets were $4.34 million and -101.94% higher than the average of -$223.16 million This consists of current assets, which were $5.94 million the lowest of the comparisions and 98.65% lower than the average of $438.62 million, less current liabilities, which were $1604.45 thousand and lower than the other companies and 99.76% lower than the average of $661.78 million

Contributing to the current assets was Cash and Short term assets which were 1.98% making it the highest and 73.79% higher than the average of 1.14%, recievables (were 98.02% and above the other companies and 297.25% higher than the average of 24.68%) and inventory (were -16.99% and the lowest and 165.53% lower than the average of $0.26) Contributing to the current liabilities were accounts payable (were 100.0% the highest of the comparisons and 339.6% higher than the average of 22.75%) and short term debt (were 0.0% making it the lowest and 100.0% lower than the average of $0.37)

As a multiple of net assets, current liabilities were 0.11% and -100.03% over the averarge of -333.74%. Current liabilities as days of sales represents were 81.84 making it the lowest and 79.96% lower than the average of 408.38.

In terms of days of sales, accounts receivables were 297.01 and above the other companies and 113.01% higher than the average of 139.44

Long term assets

In the year ending in , Aurinia Pharmaceuticals Inc net assets were $1423.07 million and above the other companies and a lot higher than the average of $161.45 million This consists of current assets, which were $1444.39 million and 13.21% lower than the average of $1664.33 million, less current liabilities, which were $21.32 million and 98.58% under the average of $1502.88 million

Contributing to the total assets were Plant and Equipment (were 0.0% the same as the comparisions) and tangible assets(were 0.0% the same as the comparisions) Contributing to the total libiatilites were long term debt (were 0.0% and lower than the other companies and 100.0% lower than the average of $0.27) and

As a multiple of total assets, total liabilities were 1.48% and 97.26% lower than the average of 53.84%.

Plots

``` ```